TruSight Oncology 500 ctDNA v2 for Automation (48 samples)
Vendor: Illumina
SKU: 20105900
Regular price
25,907.00 NIS
Sale price
Regular price
Unit price
/per
Quote Required
In stock
TSO 500 ctDNA v2 AutomatedKit
TruSight Oncology 500 ctDNA v2 is a pan-cancer NGS assay that enables in-house comprehensive genomic profiling (CGP) of circulating tumor DNA (ctDNA) in blood plasma for research.
Documents
- Liquid Biopsy and NGS: Driving translational clinical research to the next level
- Accurate quantification of cfDNA for use in TruSight Oncology 500 ctDNA
- TruSight Oncology 500 ctDNA Gene List
- Data analysis and reporting for the TruSight Oncology 500 portfolio
- Chinese (Simplified)
- TruSight Oncology 500 portfolio
- Brazilian Portuguese
- TruSight Oncology 500 ctDNA v2 provides superior performance and an improved workflow
Support Documentation
- DRAGEN TruSight Oncology 500 ctDNA Analysis Software v1.2 Documentation
- DRAGEN TruSight Oncology 500 ctDNA Analysis Software v2.6 Documentation
- DRAGEN TruSight Oncology 500 ctDNA Local Analysis Software v2.1 Documentation
- TruSight Oncology 500 ctDNA v2 Product Documentation
- DRAGEN TruSight Oncology 500 ctDNA Analysis Software v1.2 on ICA Documentation
- TruSight Oncology 500 ctDNA Checklist Documentation
- DRAGEN TruSight Oncology 500 ctDNA Analysis Software v2.5 Documentation
- DRAGEN TruSight Oncology 500 ctDNA Analysis Software v2.1.1 on ICA Documentation
Specifications
- Area of interest Cancer research, Cell & molecular biology research, Drug discovery & development, Immuno-oncology research
- Assay time 2.5–4 days from purified nucleic acid to variant results
- Automation capability Liquid handling robot(s)
- Cancer type Pan-cancer, Solid tumor
- Content specifications Targeted sequencing of DNA for a total of 1.94 Mb panel size: 523 genes for small variants, 59 genes for CNVs, 23 genes for gene rearrangements, bMSI (> 2300 loci), bTMB (1.94 Mb).
- Hands on time ~1.5 hr for automated workflow ~2.5 hr for manual workflow
- Input quantity 20 ng cfDNA (4 ml of plasma)
- Instruments NextSeq 2000 SystemNovaSeq 6000 SystemNovaSeq 6000Dx in Research ModeNovaSeq X Plus SystemNovaSeq X System
- Key use Genotyping, Targeted analysis, Tumor immunogenicity analysis
- Mechanism of action Hybrid-capture chemistry
- Method Target enrichment, Targeted DNA sequencing
- Multiplexing NextSeq 2000 System: 4 samples on P4 flow cell. NovaSeq 6000 System: 4 samples on S1 flow cell, 8 samples on S2 flow cell, 24 samples on S4 flow cell. NovaSeq X Series: 4 samples on 1.5B flow cell, 24 samples on 10B flow cell, 64 samples on 25B flow cell.
- Nucleic acid type DNA
- Specialized sample types Blood, Circulating tumor DNA
- Species category Human
- Technology Sequencing
- Variant class Blood microsatellite instability (bMSI), Blood tumor mutational burden (bTMB), Copy number variants (CNVs), Gene rearrangements, Insertions-deletions (indels), Multi-nucleotide variants (MNVs), Single nucleotide variants (SNVs)
links and documants
- Datasheet url Click here
- Source url Click here
Couldn't load pickup availability
TruSight Oncology 500 ctDNA v2 for Automation (48 samples)
Regular price
25,907.00 NIS
Sale price
Regular price
Unit price
/per
Quick order list
Free shipping on almost everything
Free Shipping
All orders over $500 are delivered to your doorstep at no extra charge.
30-Days Free Returns
Enjoy the freedom of stress-free shopping with our hassle-free and return policy.
Secure Payment
Shop with confidence knowing your payments are secure and your information